Journals / Journal of Contemporary Medicine / 2017 / Cilt: 7 - Sayı: 4

Clinical and Laboratory Findings in Various Reasons of Thrombocytopenia

Farklı Trombositopeni Sebeplerinin Klinik ve Laboratuvar Bulguları

Pages
316–322
Publication Date
2017-12-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Clinical reflections may help to identify the cause of thrombocytopenia but not sufficiently demonstrative for diagnosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Thrombocytopenia is an important cause of bleeding.
📊
Key Findings & Data:Methods: A total of 100 patients with thrombocytopenia who were treated in Hacettepe University between 1993 and 2011, 29 with thrombotic thrombocytopenic purpura (TTP), 36 with immune thrombocytopenic purpura (ITP), and 35 with aplastic anemia (AA), were included in the study.
💡
Conclusion & Impact:Clinical reflections may help to identify the cause of thrombocytopenia but not sufficiently demonstrative for diagnosis.
🔬Design:Review & Systematic Survey
📍Scope:2011 Verileri
⚙️Variables:Trombotik Trombositopenik Purpura · İmmün Trombositopeni · Kazanılmış Aplastik Anemi

Abstract

Aim: Thrombocytopenia is an important cause of bleeding. Different clinical conditions associated with thrombocytopenia and their reflections to the hemostatic table will be examined in this study. Methods: A total of 100 patients with thrombocytopenia who were treated in Hacettepe University between 1993 and 2011, 29 with thrombotic thrombocytopenic purpura (TTP), 36 with immune thrombocytopenic purpura (ITP), and 35 with aplastic anemia (AA), were included in the study. Clinical features and laboratory values were reviewed. Results: The median ages were 42.2 ± 19.5 years, 40.1 ± 16.3 years, and 34.4 ± 14.7 years in patients with TTP, ITP, and AA, respectively. The majority of patients were female in the TTP and ITP groups, but the female to male ratio was nearly equal in the AA group. Thrombosis, fever, and sepsis were more frequently seen in TTP. The most common bleeding type was subcutaneous bleeding in all patient groups. Among patients with TTP, twenty-five patients (86, 2%) had fever, 26 patients (89, 7%) had a neurologic disorder, and 16 patients (55, 1%) had renal dysfunction. Regarding the diagnostic criteria of TTP, 13 patients (44, 8%) met five, 12 (41, 4%) patients met four and 4 (13, 8%) patients met three criteria. Conclusion: The severity of clinical presentation and underlying disorders are the most important points with which to approach patients with thrombocytopenia. Clinical reflections may help to identify the cause of thrombocytopenia but not sufficiently demonstrative for diagnosis.

Özet

Amaç: Trombositopeni önemli bir kanama nedenidir. Bu çalışmada farklı nedenlere bağlı trombositopeniler ve onların hemostatik tabloya klinik ve laboratuar açısından yansımaları irdelenmiştir.

🔖

Cite This Article

AKIN, S., AKIN, Ş., AKYOL, T. K., HAZNEDAROĞLU, İ. (2017). Clinical and Laboratory Findings in Various Reasons of Thrombocytopenia. Journal of Contemporary Medicine, Cilt: 7 - Sayı: 4, 316–322. https://ajindex.com/articles/775390

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Williamson DR, Albert M, Heels-Ansdell D, Arnold DM, Lauzier F, Zarychanski R, Crowther M, Warkentin TE, Dodek P, Cade J et al: Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest 2013, 144(4):1207-1215
  2. Kappler S, Ronan-Bentle S, Graham A: Thrombotic microangiopathies (TTP, HUS, HELLP). Emergency medicine clinics of North America 2014, 32(3):649-671
  3. Stasi R: How to approach thrombocytopenia. Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program 2012, 2012:191-197
  4. Veneri D, Franchini M, Randon F, Nichele I, Pizzolo G, Ambrosetti A: Thrombocytopenias: a clinical point of view. Blood transfusion = Trasfusione del sangue 2009, 7(2):75-85
  5. Townsley DM, Desmond R, Dunbar CE, Young NS: Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes. International journal of hematology 2013, 98(1):48-55
  6. Abadi U, Yarchovsky-Dolberg O, Ellis MH: Immune thrombocytopenia: recent progress in pathophysiology and treatment. Clinical and applied thrombosis/hemostasis: official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2015, 21(5):397-404
  7. Galbusera M, Noris M, Remuzzi G: Thrombotic thrombocytopenic purpura--then and now. Seminars in thrombosis and hemostasis 2006, 32(2):81-89
  8. Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F, Cheung B, Machin SJ, British Committee for Standards in H: Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. British journal of haematology 2012, 158(3):323-335
  9. Zheng XL, Kaufman RM, Goodnough LT, Sadler JE: Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood 2004, 103(11):4043-4049
  10. McCrae KR, Bussel JB, Mannucci PM, Remuzzi G, Cines DB: Platelets: an update on diagnosis and management of thrombocytopenic disorders. Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program 2001:282-305
  11. Gauer RL, Braun MM: Thrombocytopenia. American family physician 2012, 85(6):612-622
  12. Kim KY, Kim KE, Kim KH: Mean platelet volume in the normal st